Clinical Trials Directory

Trials / Completed

CompletedNCT01091714

Is Omega-3 Fatty Acid Red Blood Cell (RBC) Saturation Product Dependent?

Is Omega-3 Fatty Acid RBC Saturation Product Dependent?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Bucci Laser Vision Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a specific product utilized within this study.

Detailed description

To demonstrate that RBC saturation of the Omega-3 fatty acids reaching cardioprotective levels as proven with the HS-Omega-3 Index test will be achieved most efficiently depending on a specific product utilized within this study. The HS-Omega-3 Index is a new test that measures blood levels of the cardioprotective omega-3 fatty acids, EPA and DHA. RBS saturation is being measured to identify how much Omega 3 is in the blood.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3Approximately 2400 mg of Omega-3s taken once daily by capsule, taken for the duration of the study.
DIETARY_SUPPLEMENTOmega-3Approximately 2240 mg of Omega-3s taken once daily by capsule, taken for the duration of the study.
DIETARY_SUPPLEMENTOmega-3Approximately 2332 mg of Omega-3s taken once daily by capsule, taken for the duration of the study.

Timeline

Start date
2010-10-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-03-24
Last updated
2011-10-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01091714. Inclusion in this directory is not an endorsement.